A study from the University of Alberta has identified genetic mutations in scleroderma patients, a finding that may lead to new...

New findings suggest that a subset of fibroblasts may play a key role in the development of scleroderma, a finding researchers suggest...

A study investigating patients diagnosed with, or at risk for, early diffuse systemic sclerosis indicates that standard scleroderma...

A new study suggests that with current immunosuppressive therapies, 20% of people with early or at-risk dcSSc experienced worsening of skin.

Tomorrow, May 29, 2021, Chronicle Companies, in collaboration with Mallinckrodt Pharmaceuticals and Scleroderma Canada, is presenting the...

Fat grafts enhanced with adipose-derived stem cells (ADSCs) may be a safe and feasible alternative treatment for facial atrophy...